Bioretec Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- Bioretec Ltd.'s estimated annual revenue is currently $6.8M per year.
- Bioretec Ltd.'s estimated revenue per employee is $155,000
Employee Data
- Bioretec Ltd. has 44 Employees.
- Bioretec Ltd. grew their employee count by 33% last year.
Bioretec Ltd.'s People
Name | Title | Email/Phone |
---|
Bioretec Ltd. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Bioretec Ltd.?
Bioretec Ltd. is a medical device company focusing on the development of strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. Our products are used worldwide, and we continue to further develop materials and products for high load-bearing clinical applications.
keywords:N/AN/A
Total Funding
44
Number of Employees
$6.8M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bioretec Ltd. News
... Medtronic Inc., Stryker Corporation, Biomatlante, Arthrex Inc., Bioactive Bone Substitutes, Lasak Ltd, Bioretec Ltd., Noraker and Septodont Holding.
Acumed, Cardial Health, Advanced Orthopaedic Solutions, Bioretec Limited, DePuy Synthes, Smith & Nephew, Integra LifeSciences, Stryker, Wright Medical Group...
Bioretec Ltd Company announcement 13 April 2022 at 3 p.m. EEST. The Annual General Meeting of shareholders of Bioretec Ltd was held today,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.7M | 45 | 41% | N/A |
#2 | $14.4M | 45 | 36% | N/A |
#3 | $5.3M | 46 | 35% | N/A |
#4 | $3.8M | 48 | 4% | N/A |
#5 | $6.4M | 49 | 58% | N/A |